English
Back
Download
Log in to access Online Inquiry
Back to the Top

$Amicus Therapeutics (FOLD.US)$ Announces Topline Results fr...

$Amicus Therapeutics (FOLD.US)$ Announces Topline Results from Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of Idiopathic Pulmonary Fibrosis.

GALACTIC-1 trial did not meet its primary endpoint.
Galecto to discontinue the development of GB0139.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
17K Views
Comment
Sign in to post a comment
    Email me Omglolz1989@gmail.com
    7340
    Followers
    333
    Following
    198K
    Visitors
    Follow

    Market Insights

    Market Hot Picks Market Hot Picks
    Unlock Now

    Reassessing Chinese Assets

    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.